Rima M Saliba

Rima M Saliba

UNVERIFIED PROFILE

Are you Rima M Saliba?   Register this Author

Register author
Rima M Saliba

Rima M Saliba

Publications by authors named "Rima M Saliba"

Are you Rima M Saliba?   Register this Author

69Publications

2420Reads

19Profile Views

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens.

Biol Blood Marrow Transplant 2019 05 11;25(5):1039-1044. Epub 2019 Jan 11.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791193002
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2019.01.009DOI Listing
May 2019

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2018 07 12;24(7):1514-1520. Epub 2018 Feb 12.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.02.003DOI Listing
July 2018

Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.

Biol Blood Marrow Transplant 2017 Dec 24;23(12):2166-2171. Epub 2017 Aug 24.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889108PMC
December 2017

Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease.

Am J Surg Pathol 2017 Nov;41(11):1483-1490

Departments of *Stem Cell Transplantation and Cellular Therapy †Pathology ‡Gastroenterology, The University of Texas M.D. Anderson Cancer Center §Department of Pediatric Oncology, Baylor College of Medicine, Houston, TX ∥Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000914DOI Listing
November 2017

Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.

Biol Blood Marrow Transplant 2017 Aug 12;23(8):1359-1366. Epub 2017 May 12.

Department of Stem Cell Transplantation and Cellular Therapy, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453532PMC
August 2017

Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.

Biol Blood Marrow Transplant 2017 Jul 4;23(7):1059-1063. Epub 2017 Apr 4.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.030DOI Listing
July 2017

Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction.

Biol Blood Marrow Transplant 2009 Oct 3;15(10):1265-70. Epub 2009 Aug 3.

Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112360PMC
October 2009

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Haematologica 2009 Feb 14;94(2):249-57. Epub 2009 Jan 14.

Department of Stem Cell, Transplantation and Cellular Therapy, The University of Texas M.D., Anderson Cancer Center 1515 Holcombe Blvd., Unit 423, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.13756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635398PMC
February 2009

Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis.

Biol Blood Marrow Transplant 2008 Aug;14(8):859-66

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2008.05.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548938PMC
August 2008

Hyperacute GVHD: risk factors, outcomes, and clinical implications.

Blood 2007 Apr;109(7):2751-8

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-07-034348DOI Listing
April 2007

Risk factors for relapse after complete remission with high-dose therapy for multiple myeloma.

Leuk Lymphoma 2006 Jul;47(7):1360-4

Department of Blood and Marrow Transplantation UT-MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190500520806DOI Listing
July 2006

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation.

Biol Blood Marrow Transplant 2004 Mar;10(3):178-85

Department of Blood and Marrow Transplantation, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030-4095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2003.10.006DOI Listing
March 2004

Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma.

J Clin Oncol 2003 Dec;21(23):4407-12

Department of Blood and Marrow Transplantation, Unit 423, the University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/21/23/4407.full.pdf
Web Search
http://www.jco.org/cgi/doi/10.1200/JCO.2003.05.501
Publisher Site
http://dx.doi.org/10.1200/JCO.2003.05.501DOI Listing
December 2003

Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: the prognostic value of beta2-microglobulin and the tumor score.

Cancer 2003 Dec;98(12):2630-5

Department of Blood and Marrow Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11838DOI Listing
December 2003